Anteris Technologies
David St. Denis serves as President and a Member of the Board of Directors at Anteris Technologies since July 2017, also holding the position of Chief Operating Officer, where responsibilities include overseeing Product Development, Clinical Operations, Regulatory Affairs, Technical Operations, Quality, and Marketing with a focus on global profit and loss. Additionally, since October 2023, David St. Denis has taken on the role of Chief Executive Officer at v2vmedtech. David St. Denis holds an MBA from Babson F.W. Olin Graduate School of Business.
This person is not in any offices
Anteris Technologies
1 followers
Anteris Technologies is a structural heart company focused on developing innovative solutions to the biggest challenges facing aortic stenosis patients and their physicians. Our DurAVR™ Transcatheter Heart Valve (THV) System is designed for younger patients who need a heart valve that will last their lifetime. DurAVR™ THV is a unique, single-piece valve and its first-in-class biomimetic design replicates the normal blood flow of a healthy human aortic valve. | $AVR | ASX: AVR | #DurAVR #ADAPT #structuralheart #TAVR #TAVI #cardiology